 |
Updated :Nov 2009
2009 Manuscripts and Chapters
- Antzelevitch C, Burashnikov A. Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation.
J Electrocardiol. 2009; 42:543-548.
PMID:19698954
- Viskin S, Rosso R, Márquez MF, Antzelevitch C. The acquired Brugada syndrome and the paradox of choice.
Heart Rhythm. 2009;6:1342-1344.
PMID:19716090
- Zhou Q, Zygmunt AC, Cordeiro JM, Siso-Nadal F, Miller RE, Buzzard GT, Fox JJ.Identification of IKr kinetics and drug binding in native myocytes.
Ann Biomed Eng. 2009;37:1294-1309.
PMID:19353268
- McPate MJ, Zhang H, Cordeiro JM, Dempsey CE, Witchel HJ, Hancox JC. hERG1a/1b heteromeric currents exhibit amplified attenuation of inactivation in variant 1 short QT syndrome.
Biochem Biophys Res Commun. 2009;386:111-117.
PMID:19501051
- Burashnikov A, Antzelevitch C. New pharmacological strategies for the treatment of atrial fibrillation.
Ann Noninvasive Electrocardiol. 2009;14:290-300.
PMID:19614642
- Sicouri S, Belardinelli L, Carlsson L, Antzelevitch C. Potent antiarrhythmic effects of chronic amiodarone in canine pulmonary vein sleeve preparations.
J Cardiovasc Electrophysiol. 2009;20:803-810.
PMID:19298559
- Burashnikov A, Antzelevitch C. Atrial-selective sodium channel block for the treatment of atrial fibrillation.
Expert Opin Emerg Drugs. 2009;14:233-249.
PMID:19466903
- Hu D, Barajas-Martinez H, Burashnikov E, Springer M, Wu Y, Varro A, Pfeiffer R, Koopmann TT, Cordeiro JM, Guerchicoff A, Pollevick, GD, Antzelevitch C. A mutation in the ß3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype.
Circ Cardiovasc Genet. 2009;2:270-278.
- McPate MJ, Zhang H, Adeniran I, Cordeiro JM, Witchel HJ, Hancox JC. Comparative effects of the short QT N588K mutation at 37°C on hERG K+ channel current during ventricular, Purkinje fibre and atrial action potentials: an action potential clamp study.
J Physiol Pharmacol.2009;60:23–41.
- Cordeiro JM, Marieb M, Pfeiffer R, Calloe K, Burashnikov E, Antzelevitch C. Accelerated inactivation of the L-type calcium current due to a mutation in CACNB2b underlies Brugada syndrome.
J Mol Cell Cardiol. 2009;46:695-703.
PMID:19358333
- Nof E, Glikson M, Antzelevitch C. Genetics and sinus node dysfunction.
J Atrial Fibrillation. 2009;1:328-336.
- Viskin S, Wilde AA, Tan HL, Antzelevitch C, Shimizu W, Belhassen B. Empiric quinidine therapy for asymptomatic Brugada syndrome: time for a prospective registry.
Heart Rhythm. 2009;6:401-404.
PMID:19251219
- Calloe K, Cordeiro JM, Di Diego JM, Hansen RS, Grunnet M, Olesen SP, Antzelevitch C. A transient outward potassium current activator recapitulates the electrocardiographic manifestations of Brugada syndrome.
Cardiovasc Res. 2009;81:686-694.
PMID:19073629
- Patel C, Burke JF, Patel H, Gupta P, Kowey PR, Antzelevitch C, Yan GX. Is there a significant transmural gradient in repolarization time in the intact heart? Cellular basis of the T wave: a century of controversy.
Circ Arrhythm Electrophysiol. 2009;2:80-88.
|
